IONS
Price
$35.29
Change
+$0.05 (+0.14%)
Updated
Jun 6 closing price
Capitalization
5.61B
53 days until earnings call
NVO
Price
$74.63
Change
+$1.98 (+2.73%)
Updated
Jun 6 closing price
Capitalization
323.27B
59 days until earnings call
Interact to see
Advertisement

IONS vs NVO

Header iconIONS vs NVO Comparison
Open Charts IONS vs NVOBanner chart's image
Ionis Pharmaceuticals
Price$35.29
Change+$0.05 (+0.14%)
Volume$1.2M
Capitalization5.61B
Novo-Nordisk A/S
Price$74.63
Change+$1.98 (+2.73%)
Volume$9.55M
Capitalization323.27B
IONS vs NVO Comparison Chart
Loading...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IONS vs. NVO commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IONS is a StrongBuy and NVO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (IONS: $32.43 vs. NVO: $68.60)
Brand notoriety: IONS and NVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IONS: 170% vs. NVO: 75%
Market capitalization -- IONS: $5.61B vs. NVO: $323.27B
IONS [@Biotechnology] is valued at $5.61B. NVO’s [@Biotechnology] market capitalization is $323.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IONS’s FA Score shows that 0 FA rating(s) are green whileNVO’s FA Score has 2 green FA rating(s).

  • IONS’s FA Score: 0 green, 5 red.
  • NVO’s FA Score: 2 green, 3 red.
According to our system of comparison, NVO is a better buy in the long-term than IONS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IONS’s TA Score shows that 4 TA indicator(s) are bullish while NVO’s TA Score has 5 bullish TA indicator(s).

  • IONS’s TA Score: 4 bullish, 6 bearish.
  • NVO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NVO is a better buy in the short-term than IONS.

Price Growth

IONS (@Biotechnology) experienced а -3.19% price change this week, while NVO (@Biotechnology) price change was +0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

IONS is expected to report earnings on Jul 31, 2025.

NVO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVO($323B) has a higher market cap than IONS($5.61B). IONS YTD gains are higher at: -7.237 vs. NVO (-18.966).
IONSNVOIONS / NVO
Capitalization5.61B323B2%
EBITDA-353.72MN/A-
Gain YTD-7.237-18.96638%
P/E RatioN/A20.27-
Revenue705MN/A-
Total Cash2.3BN/A-
Total Debt1.42BN/A-
FUNDAMENTALS RATINGS
IONS vs NVO: Fundamental Ratings
IONS
NVO
OUTLOOK RATING
1..100
1713
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
10063
SMR RATING
1..100
9815
PRICE GROWTH RATING
1..100
5063
P/E GROWTH RATING
1..100
6797
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVO's Valuation (26) in the Pharmaceuticals Major industry is significantly better than the same rating for IONS (96) in the Biotechnology industry. This means that NVO’s stock grew significantly faster than IONS’s over the last 12 months.

NVO's Profit vs Risk Rating (63) in the Pharmaceuticals Major industry is somewhat better than the same rating for IONS (100) in the Biotechnology industry. This means that NVO’s stock grew somewhat faster than IONS’s over the last 12 months.

NVO's SMR Rating (15) in the Pharmaceuticals Major industry is significantly better than the same rating for IONS (98) in the Biotechnology industry. This means that NVO’s stock grew significantly faster than IONS’s over the last 12 months.

IONS's Price Growth Rating (50) in the Biotechnology industry is in the same range as NVO (63) in the Pharmaceuticals Major industry. This means that IONS’s stock grew similarly to NVO’s over the last 12 months.

IONS's P/E Growth Rating (67) in the Biotechnology industry is in the same range as NVO (97) in the Pharmaceuticals Major industry. This means that IONS’s stock grew similarly to NVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IONSNVO
RSI
ODDS (%)
Bearish Trend 12 days ago
81%
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
75%
Bearish Trend 12 days ago
57%
Momentum
ODDS (%)
Bearish Trend 12 days ago
72%
Bullish Trend 12 days ago
60%
MACD
ODDS (%)
Bearish Trend 12 days ago
75%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
69%
Bullish Trend 12 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
67%
Bullish Trend 12 days ago
66%
Advances
ODDS (%)
Bullish Trend 20 days ago
61%
Bullish Trend 20 days ago
66%
Declines
ODDS (%)
Bearish Trend 18 days ago
70%
Bearish Trend 26 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 12 days ago
53%
Aroon
ODDS (%)
Bullish Trend 12 days ago
61%
Bullish Trend 12 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

IONS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IONS has been loosely correlated with ALNY. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IONS jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IONS
1D Price
Change %
IONS100%
-2.67%
ALNY - IONS
55%
Loosely correlated
-1.56%
IDYA - IONS
50%
Loosely correlated
+0.72%
ARWR - IONS
49%
Loosely correlated
+1.24%
RCKT - IONS
49%
Loosely correlated
+6.44%
ROIV - IONS
48%
Loosely correlated
-1.30%
More

NVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been loosely correlated with BCAB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if NVO jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-2.61%
BCAB - NVO
39%
Loosely correlated
+2.18%
TECH - NVO
36%
Loosely correlated
-1.56%
ROIV - NVO
33%
Poorly correlated
-1.30%
IONS - NVO
32%
Poorly correlated
-2.67%
CPRX - NVO
30%
Poorly correlated
-1.21%
More